ECSP972295A - METHODS AND COMPOSITIONS TO MODULATE THE HUMAN SEXUAL RESPONSE - Google Patents

METHODS AND COMPOSITIONS TO MODULATE THE HUMAN SEXUAL RESPONSE

Info

Publication number
ECSP972295A
ECSP972295A ECSP972295A ECSP972295A EC SP972295 A ECSP972295 A EC SP972295A EC SP972295 A ECSP972295 A EC SP972295A EC SP972295 A ECSP972295 A EC SP972295A
Authority
EC
Ecuador
Prior art keywords
sexual response
methods
modulate
compositions
human sexual
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Fred Lowrey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP972295 priority Critical patent/ECSP972295A/en
Publication of ECSP972295A publication Critical patent/ECSP972295A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Este invento se dirige a métodos mejorados para la modulación de la respuesta sexual mediante la administración de una combinación administrada oralmente de un agente vasodilatador a la circulación sanguinea, con lo que se modula la respuesta sexual a solicitud.This invention is directed to improved methods for modulating the sexual response by administering an orally administered combination of a vasodilating agent to the blood circulation, thereby modulating the sexual response upon request.

ECSP972295 1997-10-28 1997-10-28 METHODS AND COMPOSITIONS TO MODULATE THE HUMAN SEXUAL RESPONSE ECSP972295A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP972295 ECSP972295A (en) 1997-10-28 1997-10-28 METHODS AND COMPOSITIONS TO MODULATE THE HUMAN SEXUAL RESPONSE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP972295 ECSP972295A (en) 1997-10-28 1997-10-28 METHODS AND COMPOSITIONS TO MODULATE THE HUMAN SEXUAL RESPONSE

Publications (1)

Publication Number Publication Date
ECSP972295A true ECSP972295A (en) 1999-01-19

Family

ID=42043124

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP972295 ECSP972295A (en) 1997-10-28 1997-10-28 METHODS AND COMPOSITIONS TO MODULATE THE HUMAN SEXUAL RESPONSE

Country Status (1)

Country Link
EC (1) ECSP972295A (en)

Similar Documents

Publication Publication Date Title
ES2140847T3 (en) PROCEDURES AND FORMULATIONS TO MODULATE THE HUMAN SEXUAL RESPONSE.
PT1035834E (en) OSMOTIC DOSE FORMAT COMPREHENDING FIRST AND SECOND COATINGS
ES2160712T3 (en) NEW PHARMACEUTICAL PREPARATION FOR PAIN TREATMENT.
PT998287E (en) USES OF LEVOBUPIVACAINE
ES535860A0 (en) PROCEDURE FOR OBTAINING AN AGENT FOR THE TRANSDERMAL APPLICATION OF ACTIVE MEDICINAL SUBSTANCES
CY1110376T1 (en) USE OF A COMPOSITION INCLUDING FORMOTEROL AND BUDESONIDE TO PREVENT OR THERAPEUTIC IMMUNITY
CY1111153T1 (en) FORM OF OSMOTIC DOSAGE OF PERSONAL LIFE
YU49026B (en) THE USE OF 17 ß -(N-TERT-BUTYLCARBAMOYIL)-4-AZA-5-ALPHA-ANDROST-1-ENE-3-ONE FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ANDROGENIC ALOPECIA
ES2194050T3 (en) USE OF BISPHOSPHONATES TO INHIBIT THE OSEA RESORTION AFTER THE IMPLEMENTATION OF AN OSEA PROTESIS.
ES2191329T3 (en) USE OF XANTOFILS IN MEDICINES FOR THE IMPROVEMENT OF THE DURATION OF MUSCLE FUNCTION OR THE TREATMENT OF DISORDERS OR MUSCULAR DISEASES.
NO924209L (en) DOSAGE FORM FOR ADMINISTRATION OF ANTI-PARKINSON AGENT
AR011846A1 (en) A PHARMACEUTICAL COMPOSITION, AND THE PROCEDURE TO PREPARE IT
ES2099428T3 (en) PHARMACEUTICAL COMPOSITIONS FOR INHALATION.
BR0211673A (en) Dermal therapy using phosphate derivatives of electron transfer agents
ES2172572T3 (en) PHARMACEUTICAL EMULSION
ES2158108T3 (en) IN OVO VACCINATION AGAINST COCCIDIOSIS.
PT777484E (en) INTRAVENOUS FORMULATIONS OF ALENDRONATE
SE9700885D0 (en) New pharmaceutical formulation
ES2168766T3 (en) PHARMACEUTICAL PREPARATION THAT INCLUDES THE PROVIDED VWF.
KR970025615A (en) Cancer metastasis inhibitor
NO975140L (en) Transdermal therapeutic system (TTS) for the administration of testosterone
ECSP972295A (en) METHODS AND COMPOSITIONS TO MODULATE THE HUMAN SEXUAL RESPONSE
AR018321A1 (en) A DOSAGE FORM OF PROLONGED LIBERATION THAT INCLUDES OXIBUTININE AND THE USES OF OXIBUTININE AND THE DOSAGE FORM OF PROLONGED LIBERATION.
ES2161809T3 (en) USE OF OSTEOBLASTIC PROLIFERATIVE FACTOR.
MY117556A (en) Methods and formulations for modulating the human sexual response